1st Quarter - Report
CEPHEID for CEPHEID
Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
issues related to diagnostic testing and reimbursement related to COVID testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE M SCHOONMAKER | — |
| ANGELA STEWART | Legislative Counsel, Senator John W. Warner (R-VA) |
Health Issues HCR
issues related to diagnostic testing, issues related to responding to the current COVID-19 pandemic and future pandemics; S. 2209/H.R. 4128, the Verifying Accurate Leading-Edge IVCT Development Act of 2021 (VALID); S. 3799 the PREVENT Pandemics Act; H.R. 6851, No Surprises for COVID-19 Tests Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE M SCHOONMAKER | — |
| ANGELA STEWART | Legislative Counsel, Senator John W. Warner (R-VA) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.